Business Context and Reporting Period
Company: NOVAVAX INC
Filing Type: Form 8-K (Current Report)
Date of Report: July 18, 2000
Event: Change in Registrant's Certifying Accountant
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the dismissal of the independent auditor and does not contain financial statement data.
Material Changes
- Accountant Dismissal: On July 18, 2000, Novavax, Inc. dismissed PricewaterhouseCoopers LLP as its independent accountants.
- Board Approval: The decision was participated in and approved by the Registrant's Board of Directors.
- Audit History: Reports for the past two fiscal years contained no adverse opinions, disclaimers, or qualifications regarding uncertainty, audit scope, or accounting principles.
- Disagreements: There were no disagreements with PricewaterhouseCoopers LLP on accounting principles, practices, disclosures, or auditing scope/procedures during the two most recent fiscal years and through July 18, 2000.
- Reportable Events: No reportable events (as defined in Regulation S-K Item 304(a)(1)(v)) occurred during the relevant period.
- New Accountant: As of July 24, 2000, the Registrant has not engaged new independent accountants.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on future operations, specific risks, contingencies, or unusual items beyond the change in auditor.
Investor Verification Checklist
- Verify the reason for the dismissal of PricewaterhouseCoopers LLP, as the filing states no disagreements occurred.
- Confirm the timeline for the engagement of a new independent accounting firm, as none was engaged as of July 24, 2000.
- Review the letter from PricewaterhouseCoopers LLP (Exhibit 16) to confirm their agreement with the statements made by the Registrant.